STATE OF SPECIFIC IMMUNITY IN COVID-19 PATIENTS TREATED IN AMBULATORY CONDITIONS

Authors

Imdat Efendiev
Non-commercial Joint Stock Company "Semey Medical University", Republic of Kazakhstan, East Kazakhstan region, 071400 Semey, st. Abay Kunanbayev, 103
Ersin Zhunusov
Non-commercial Joint Stock Company "Semey Medical University", Republic of Kazakhstan, East Kazakhstan region, 071400 Semey, st. Abay Kunanbayev, 103
Anargul Mansurova
Non-commercial Joint Stock Company "Semey Medical University", Republic of Kazakhstan, East Kazakhstan region, 071400 Semey, st. Abay Kunanbayev, 103
Ilyas Mukhamedzhan
SU "Apparatus of akim of the East Kazakhstan region", Republic of Kazakhstan, East Kazakhstan region 070019 Ust-Kamenogorsk, st. M. Gorky, 40.

Synopsis

The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus poses a threat to human health around the world. Great hopes in the fight against the disease are now pinned on the production of specific antibodies. Meanwhile, their characteristics and relationship with the clinical manifestations of COVID-19, the relationship with the detection of SARS-CoV-2 RNA has not yet been well studied. The aim of this work is to study the state of specific immunity in patients with COVID-19 treated on an outpatient basis.

PANDEMIC–ICT–2020
Publication
Abstracts of the First Eurasian Conference; The Coronavirus Pandemic and Critical ICT Infrastructure
PDF
Published
December 24, 2020
Series
AIJR Abstracts
Copyright (c) 2020 held by the author(s) of the individual abstract
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.